JEJens Ravn Eriksen

Jens Ravn Eriksen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jens Ravn Eriksen has a total of 357 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment of localized rectal cancer in the Nordic countries—comparison of Nordic to Dutch, ESMO, and NCCN guidelines

    by Erkki-Ville Wirta, Usman Saeed, Gijs Stuart, Laurids Østergaard Poulsen, Camilla Qvortrup, Pia Österlund, Jørgen Smeby, Jens Ravn Eriksen, Bengt Glimelius, Esther Consten, et al.

    Background: Rectal cancer treatment in Nordic countries has traditionally differed, especially regarding neoadjuvant treatment. The aim of this review is to give an overview of the current rectal cancer guidelines in the Nordics and compare these to international guidelines. Methods: Oncologists and colorectal surgeons from the Nordic countries (Denmark, Finland, Norway, and Sweden) and the Netherlands were invited to participate in this narrative review. Two consensus meetings were held to agree on the content. All authors provided recommendations from their national guidelines. In addition, recommendations from the European Society of Medical Oncology (ESMO) and from the US National Comprehensive Cancer Network (NCCN) guidelines were extracted. Results: Several differences between the included guidelines were identified. The radiological “sigmoid take-off” definition for the upper margin of the rectum has been adapted in Denmark and the Netherlands, whereas the other guidelines rely on distance from the anal verge on rigid sigmoidoscopy. Indications for direct surgery vary considerably, where the NCCN guidelines recommend more aggressive neoadjuvant treatment, primarily total neoadjuvant therapy (TNT), the Nordic and European guidelines open for direct surgery more often, and reserve especially TNT for high-risk cases. European countries more often recommend short-course radiotherapy, whereas NCCN maintains chemoradiotherapy as the mainstay. Whereas intentional and opportunistic organ preservation is an established part of the Dutch, NCCN, and ESMO guidelines, its use is mostly restricted to clinical trials in the Nordics. The Nordics and the Netherlands are restrictive in terms of adjuvant treatment, which is frequently recommended in ESMO and NCCN. Whereas neoadjuvant immunotherapy is recommended for mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) rectal cancer in NCCN, this use is off-label in Europe and not routinely recommended. Conclusion: Although all guidelines rely on the same evidence, there are considerable differences, especially in the indications and type of oncologic treatment, both in the neoadjuvant and in the adjuvant setting.

  • Open Access

    Neoadjuvant Pembrolizumab in Stages I–III Deficient Mismatch Repair Colon Cancer

    by Ismail Md Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, Mustafa Bulut, Torben Frøstrup Hansen, Lars Henrik Jensen, Hans Bjarke Md Rahr, Tove M.Sc Kirkegaard, Lukas M.Sc Balsevicius, Hans Raskov, et al.

    Objective: To investigate the safety and efficacy of single-cycle pembrolizumab in patients with localized deficient mismatch repair (dMMR) colon cancer. Background: Neoadjuvant immunotherapy has induced remarkable rates of pathologic complete response (pCR) in patients with dMMR colon cancer. However, the optimal length and type of treatment are yet to be determined. Methods: This was an investigator-initiated, multicenter, single-arm, phase II study (ClinicalTrials.gov: NCT05662527) investigating the safety and efficacy of neoadjuvant pembrolizumab in patients with stage I–III dMMR colon cancer. Patients received a single cycle of pembrolizumab 4 mg/kg (maximum 400 mg) and underwent surgery 3 to 5 weeks later. An interim safety and efficacy analysis after including 42 patients was pre-planned. The primary outcomes were safety and efficacy (pCR in more than 20% of patients). Results: Between February 2023 and September 2023, 42 patients were enrolled at 5 Danish hospitals. All patients received pembrolizumab and underwent surgery, except one patient who refused to undergo surgery. Surgery was performed a median of 32 days after pembrolizumab treatment. Twenty surgical complications were observed in 16 of 41 patients (39%), 3 of which were above Clavien-Dindo grade 2. Two were grade 3b, and 1 was a surgery-related grade 5 gastric ulcer perforation. Three adverse events were grade 3. No grade 4 or 5 adverse events were reported. Of the evaluable patients, 46% (19/41) achieved a pCR, whereas 61% had a major pathologic response. Conclusions: Neoadjuvant single-cycle pembrolizumab was well tolerated and effective in patients with localized dMMR colon cancer. Thus, the inclusion of patients was continued until 85 patients.


  • Open Access

    Initial experience and results of robotic lateral pelvic lymph node dissection in locally advanced rectal cancer—a single center experience of 17 consecutive procedures

    by Jens Ravn Eriksen, Steffen Kirstein Brisling, Ismail Gögenur

    Purpose We have evaluated lateral pelvic lymph node dissection (LPLND) in combination with rectal resection in the treatment of locally advanced rectal cancer in a specialized colorectal surgical department with a focus on safety and feasibility. Methods The study analyzed surgical-pathologic outcomes in 17 consecutive patients who underwent robotic LPLND and rectal resection between May 2018 and June 2024 at a high-volume colorectal cancer center in Denmark. Patients were selected for the procedure based on lateral lymph node (LLN) diameter ≥ 8 mm before and ≥ 5 mm after neoadjuvant treatment. Results Out of 17 patients (15 men and 2 females) included in this study, 13 patients (76%) had undergone neoadjuvant therapy. The median age was 63 years (range 35–79) with a median BMI of 25.6 kg/m2 (range 19.4–34.5). The total median operation time was 335 min (range 182–526 min) with no conversions necessary. Additional resection of structures beyond the total mesorectal excision plane was performed in eight patients (47%). The median hospital stay was 4 days (range 2–14) and one patient was readmitted within 30 days. Seven patients experienced postoperative complications within 30 days, with only one CD complication ≥ grade 3. The median number of resected LLNs was 4 (range 0–11) per patient and malignant LLNs were verified in three patients (17.6%). Conclusion This study shows that simultaneous robot-assisted LPLND and rectal resection can be performed safely and effectively in selected patients with locally advanced rectal cancer, with a short hospital stay and few readmissions and postoperative complications.


  • Open Access

    The perfect stoma: tips from a stoma nurse

    by Marianne Krogsgaard, Trine Bolette Borglit, Jens Ravn Eriksen

    More than 700 000 Europeans and 800 000 Americans live with a stoma. Stoma-related morbidity is common1; one-third of stomas are reported as being problematic within 3 weeks of surgery2 and the overall incidence of stoma-related complications is 26.5 (range 2–100) per cent3. Stoma-related complications arise mainly from patient factors and surgical technique2. Although most patient factors are not readily modifiable, focus on surgical technique can optimize outcomes for the patient. This article, written from a stoma nurse’s perspective, points to patient preparation and stoma construction as being important for the patient’s management of the stoma.


  • The effect of intracorporeal versus extracorporeal anastomosis in robotic right colectomy on perianastomotic perfusion: a substudy to a multicenter RCT

    by Niclas Dohrn, Carolin Oppermann, Helin Yikilmaz, Magnus Laursen, Faisal Khesrawi, Frederik Bjerg Clausen, Henrik Loft Jakobsen, Steffen Brisling, Jakob Lykke, Jens Ravn Eriksen, et al.

    Purpose Previous studies have shown that intracorporeal anastomosis (ICA) in minimally invasive right colectomy may improve postoperative recovery compared with extracorporeal anastomosis (ECA). It has been hypothesized that creating the anastomosis extracorporeally may cause mesenteric traction and compromised intestinal perfusion. The purpose of this study was to investigate the effect of either ICA or ECA on intestinal perfusion. Method This was a substudy to a multicenter, triple-blind randomized clinical trial comparing ICA with ECA in patients undergoing robotic right colectomy for colonic cancer. Videos from intraoperative Indocyanine Green (ICG) fluorescence imaging were analyzed with quantitative ICG perfusion assessment (q-ICG). q-ICG was performed by extracting perfusion metrics from a time-intensity curve generated from an image analysis software: FMAX: maximal fluorescence intensity, TMAX: time until maximal fluorescent signal, T1/2MAX: time until half-maximal fluorescent signal, time ratio (T1/2MAX/TMAX) and slope. Results A total of 68 patients (33 ICA and 35 ECA) were available for analysis. Demographics were similar between the groups, except for mean arterial blood pressure at the time of ICG infusion, which was significantly lower in the ICA group. We found a significantly steeper slope in the ICA group compared to the ECA group (6.3 vs. 4.7 AU/sec, P = .048). There were no significant differences in FMAX, TMAX, T1/2MAX, and time ratio. Conclusion We found evidence of an improved intestinal perfusion following ICA compared with ECA. This finding may be related to patient outcomes and should be explored further in the future. Trial registration. ClinicalTrials.gov NCT03130166.


  • Intracorporeal Versus Extracorporeal Anastomosis in Robotic Right Colectomy

    by Niclas Dohrn, Helin Yikilmaz, Magnus Laursen, Faisal Khesrawi, Frederik Bjerg Clausen, Frederik Sørensen, Henrik Loft Jakobsen, Steffen Brisling, Jakob Lykke, Jens Ravn Eriksen, et al.

    Objective: To determine if minimally invasive right colectomy with intra-corporeal anastomosis improves postoperative recovery compared to extra-corporeal anastomosis. Background: Previous trials have shown that intracorporeal anastomosis improves postoperative recovery; however, it has not yet been evaluated in a setting with optimized perioperative care or with patient-related outcome measures. Methods: This was a multicenter, triple-blind, randomized clinical trial at two high-volume colorectal centers with strict adherence to optimized perioperative care pathways. The patients underwent robotic right colectomy with either intracorporeal or extracorporeal anastomosis. The primary outcome was patient-reported postoperative recovery measured using the “Quality of Recovery–15” questionnaire. ClinicalTrials.gov NCT03130166. Results: A total of 89 patients were randomized and analyzed according to the “Intention-to-treat”-principle. We found no statistically significant differences in patient-reported recovery between the groups. Postoperative pain, nausea, time to ambulation, time to first passage of flatus/stool, length of hospital stay, and pathophysiological tests showed no differences either. The duration of time to create the anastomosis was significantly longer with intracorporeal anastomosis (17 vs 13 min, P = 0.003), while all other intraoperative, postoperative, and pathology variables showed no difference. Conclusion: There were no significant differences in postoperative recovery between the two groups.


    • 29 July 2019
      • Vol. 181  (31)

    [Suspicious malignant lateral pelvic lymph nodes in locally advanced rectal cancer].

    by Jens Ravn Eriksen, Steffen Brisling

    Total mesorectal excision and neoadjuvant radio-chemo-therapy is the standard treatment of locally advanced rectal cancer. In 4-12% of all patients a local recurrence will develop, with more than half located on the lateral pelvic side wall. It is an ongoing controversy, whether malignant lateral pelvic lymph nodes should be considered as regional or distant disease. The role of lateral pelvic lymph node dissection in a Western treatment setting is not clarified, but in this review, we argue that it may reduce the risk of local recurrence in selected patients with locally advanced disease.


  • Why still in hospital after laparoscopic colorectal surgery within an enhanced recovery programme?

    by P. Munk‐Madsen, J. R. Eriksen, H. Kehlet, I. Gögenur

    Aim: Enhanced recovery after surgery programmes in elective colorectal surgery have been developed and implemented widely, but a subgroup of patients may still require longer hospital stays than expected. The aim of this study was to identify and describe factors compromising early postoperative recovery by asking ‘why is the patient still in hospital today?’ after laparoscopic colorectal cancer surgery within an enhanced recovery after surgery programme.Method: Patients undergoing elective laparoscopic colorectal cancer resection were evaluated postoperatively with predefined potential reasons for still being in hospital. The primary outcome was ‘reason for still being in hospital’ on postoperative day 0–4 and secondarily length of stay with a focus on differences between patients with and without a stoma.Results: Ninety‐six patients having colorectal cancer surgery were included. The median length of stay for the whole group was 3 days (range 1–14). The four dominant causes for patients without a stoma to be in hospital were lack of gastrointestinal function, lack of early mobilization, lack of normal micturition and nausea. Patients with a stoma stayed in hospital due to stoma training, lack of gastrointestinal function, lack of free micturition and a miscellaneous ‘others’ group.Conclusion: Delayed gastrointestinal function, insufficient mobilization, poor urinary function and stoma care training have been characterized as dominant compromising factors for postoperative recovery. Together with a focus on frailty, future studies should focus on improving early mobilization, prevention and treatment of postoperative urinary retention and improved stoma care training, in order to minimize delay in postoperative recovery and discharge.


  • Postoperative Urinary Retention After Laparoscopic Colorectal Resection with Early Catheter Removal: A Prospective Observational Study

    by Jens Ravn Eriksen, Pia Munk‐Madsen, Henrik Kehlet, Ismail Gögenur

    Background: Early catheter removal is essential to enhance postoperative mobilization and recovery, but may carry a risk of urinary retention. This study aimed to evaluate a standardized regimen for early postoperative catheter removal and re‐catheterization in patients undergoing elective laparoscopic colorectal cancer surgery within an optimal ERAS setting.Methods: This was a single‐center prospective study of patients undergoing elective minimally invasive colorectal resection and postoperative catheter removal within 24 h, with a re‐catheterization threshold of 800 ml bladder volume. The primary outcome was postoperative urinary retention rate, and the secondary outcomes were time of catheter removal and length of stay with a special focus on differences between colon and rectal resections.Results: A total of 113 patients were included in the study, and 87 patients were eligible for the final analysis. Rectal resection was performed in 22 of 87 patients, and all operations were performed with minimally invasive technique. The conversion rate was 3.5%, and 30‐day mortality was 0%. More than 95% of the patients had their catheter removed within 24 h with no difference between rectal and colonic resections. Postoperative urinary retention was observed in 9% of all patients (rectum 18% vs. colon 6%, p = 0.11). One patient had an indwelling catheter at discharge, but all patients had free voluntary micturition at 30‐day follow‐up. Median length of stay was 3 days (1–13 days).Conclusions: Catheter removal within 24 h of surgery using a re‐catheterization threshold of 800 ml is safe and reduces unnecessary re‐catheterizations following minimally invasive colorectal resection.


  • Orthostatic intolerance in enhanced recovery laparoscopic colorectal resection

    by Jens R. Eriksen, Pia Munk‐Madsen, Henrik Kehlet, Ismail Gögenur

    Background: Orthostatic hypotension (OH) and intolerance (OI) are common findings in the early postoperative period after major surgery and may delay early mobilization. The mechanism of impaired orthostatic competence and OI symptoms is not fully understood, and specific data after colorectal surgery with well‐defined perioperative care regimens and mobilization protocols are lacking. The aim of this study was to investigate the prevalence, possible risk factors and the impact of OI in patients undergoing elective minimal invasive colorectal cancer resection.Methods: A prospective single‐centre study with an optimal enhanced recovery program and multimodal analgesic treatment. OI and OH were evaluated using a well‐defined mobilization protocol preoperatively and 6 hour and 24 hour postoperatively.Results: A total of 100 patients were included in the data analysis. The overall median length of stay was 3 days (1‐38). OI was observed in 53% of the patients 6 hour postoperatively and in 24% at 24 hour. OI at 6 hour postoperatively was associated with younger age, lower BMI, and female gender. At 24 hour postoperatively, female gender and ASA class >1 was associated with OI. Opioid consumption and intravenous fluid during the first 24 hour was not associated with OI. Postoperative complications were equally observed between patients with and without OI. Although not statistically significant, patients with OI at 24 hour postoperatively had prolonged LOS (mean 4.0 vs 7.5 days, P = 0.069) compared with patients without OI.Conclusion: Postoperative orthostatic intolerance is a common problem during the first 24 hour following laparoscopic colorectal resection and may be followed by delayed recovery.